|
Jun 24
|
Sector Update: Health Care Stocks Rise in Late Afternoon Trading
|
|
Jun 24
|
Novo Nordisk to Invest $4.1 Billion in New Facility in North Carolina
|
|
Jun 24
|
Wegovy-maker Novo Nordisk to spend $4.1 billion to boost US manufacturing
|
|
Jun 24
|
Novo Nordisk announces 4.1 billion USD investment to expand US manufacturing capacity adline
|
|
Jun 24
|
How Lilly is joining Novo in the crusade to circumvent Medicare's block on weight loss drugs
|
|
Jun 24
|
European Equities Close Higher on Monday; EU Probes Apple for Breach of Digital Competition Law
|
|
Jun 24
|
ADA 2024: Altimmune’s GLP-1 drug shows weight loss potential
|
|
Jun 24
|
Investors Heavily Search Novo Nordisk A/S (NVO): Here is What You Need to Know
|
|
Jun 24
|
‘Ozempic face’ supplements to combat side effects of rapid weight loss
|
|
Jun 24
|
Novo fills in positive picture for preventive hemophilia drug
|
|
Jun 23
|
Novo Nordisk A/S: Mim8 demonstrated superior reductions in annualised bleeding rate (ABR) compared to on-demand and prior prophylaxis treatment in people with haemophilia A
|
|
Jun 21
|
Zealand Pharma says weight loss drug could be comparable to GLP1-RAs
|
|
Jun 21
|
WHO warns of “harmful” fake Ozempic in circulation in Americas and Europe
|
|
Jun 21
|
The Best Could Be Yet to Come for Novo Nordisk and Ozempic
|
|
Jun 20
|
Novo Nordisk (NVO) Gains As Market Dips: What You Should Know
|
|
Jun 20
|
Obesity-Drug Developers Look at What’s Next for a $100 Billion Market
|
|
Jun 20
|
WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugs
|
|
May 11
|
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
|
|
May 10
|
Novo Nordisk enters deal to develop obesity therapy
|
|
May 9
|
Making Money Off the Weight-Loss Revolution Has Even Wall Street Befuddled
|